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ABSTRACTSResults: 279 patients underwent surgery for colorectal cancer during this
period.80.3% were laparoscopic and 19.7% open. The conversion rate was
13.8% (Inter-surgeon range 11-17%). The median follow up was 50 months.
The overall mortality rate was 17.9%. Patients that had undergone lapa-
roscopic surgery for colorectal cancer had a signiﬁcant difference in their
overall mortality rate over those that were converted (14.5% v's 32.2%;
p¼0.02). For disease speciﬁc related mortality laparoscopic surgery
resulted in less mortality than open for non metastatic disease (AJCC Stage
I, II; 5.2% v's 17.9%; p¼0.04).
Conclusions: In summary, overall mortality and disease speciﬁc survival is
worse after conversion. Laparoscopic colorectal cancer surgery should only
be undertaken by speciﬁc surgeons in specialised MIS units with low
conversion rates.
1151: SHORT TERM OUTCOMES IN LAPAROSCOPIC VERSUS OPEN
APPROACH IN LEFT AND RIGHT HEMICOLECTOMIES WITHIN AN
ENHANCED RECOVERY PROGRAMME
Kam Wa Jessica Mok, Zia Moinuddin, Lyndon Jones. Royal Blackburn
Hospital, Blackburn, UK
Short term outcome beneﬁts in laparoscopic colectomies remains
debatable. We compared the short-term outcomes between
laparoscopic and open surgery and compared these with left and right
hemicolectomies.
Data was collected from enhanced recovery programme database between
2009 and 2011. 61 patients underwent left hemicolectomy (laparoscopic to
open ratio, 2:3) and 102 had right hemicolectomy (laparoscopic to open
ratio, 5:8). Short term and postoperative outcomes were compared.
Hospital staywas shorter in the laparoscopic groupcompared toopen inboth
left hemicolectomy (7 days compared to 9, p¼<0.03) and right hemi-
colectomy (6 compared to7.5days, p< 0.02). Complication rateswerehigher
amongst patient who underwent open surgery for left hemicolectomies
(complication rate of laparoscopic versus open ¼29.17% versus 51.35%).
However there were no differences in complication rates when comparing
the two approaches in right hemicolectomies. Rate of ileus was higher in
patients who had open left hemicolectomies, but there was no difference in
rate of ileus amongst right hemicolectomy open or laparsocopic approach.
Laparoscopic colorectal surgery reduces length of hospital stay in both left
and right hemicolectomies. It is also associated with lower morbidity in
patients undergoing left hemicolectomies but does not improve morbidity
in patients undergoing right hemicolectomies.
1165: OPTIMIZATION OF PERI-OPERATIVE HDU CARE FOR ELECTIVE
COLORECTAL PATIENTS
Khurram Siddique, Raza Cheema, Promad Bapat, Liviu Titu. Wirral
University Hospitals NHS Trust, Wirral, UK
Objectives: To review the care of high-risk elective colorectal patients with
regards to timing of discharge from the HDU & its effects on post-op
complications, re-admission to HDU, length of stay (LOS) and mortality.
Methods: All elective colorectal patients admitted to HDU during 2010
were included. Patients were divided into two groups with regards to their
stay on HDU: Group1 < 48 hrs & Group2 >48 hrs. Data regarding demo-
graphics, post-op complications, re-admission & mortality were collected
& analysed using SPSS version 14.
Results:Out of the total of 40 patients, 21 were females with a median age
of 74 (range 45-92). The number of patients in group 1 & 2 were 26 and 14
respectively. Laparoscopic procedures were performed in 31 patients.
Post-op complications were higher (72.2% Vs 27.8%, p<0.04) & length of
stay was signiﬁcantly longer [8 (IQR 4-41) Vs 6.5(4-12) p<0.03)]; amongst
group 1 than group 2 patients. Four patients in group 1 were re-admitted
to HDU. No mortality was reported.
Conclusion: Early discharge from the HDU is associated with a signiﬁcant
risk of complications; re-admission (15.3%) and a prolonged length of stay.
Ensuring a minimum stay of 48 hrs would reduce morbidity thus opti-
mizing HDU patient care.
1194: METABOLIC EFFECTS OF CHEMORADIOTHERAPY IN RECTAL
CANCER PATIENTS
Maryam Alfa-wali 1, Diana Tait 2, Hector Keun 1, Anthony
Antoniou 1. 1 Imperial College, London, UK; 2Royal Marsden NHS
Foundation Trust, London, UKAim:Neo-adjuvant chemoradiotherapy is part of the standard treatment of
care for down staging rectal cancers prior to surgery. However, the exact
impact of treatment response is a challenge to predict, with toxicity of
treatment being an added complication. The aim of the study was
to investigate themetabolic alterations of rectal cancer patients undergoing
therapy using proton nuclear magnetic resonance spectroscopy (1H NMR).
Methods: Twenty-four specimens were obtained from patients with rectal
cancer and controls. Plasma samples were used for the 1H NMR experi-
ments. All 1H NMR spectra were acquired using a Bruker DRX600C spec-
trometer (Bruker, Germany). Pattern recognition and statistical analysis
were performed using MATLAB and SIMCA software.
Results: Higher levels in lactate and choline metabolites were seen in,
rectal cancer patients undergoing chemoradiotherapy compared to
controls. Statistically signiﬁcant changes between the groups were also
observed in low-density lipoproteins, glycoproteins and amino acids such
as valine and glutamine.
Conclusion: Lipids in the form of phospholipids for cell membrane
synthesis were found to account for the distinct separation of samples
based on response to chemoradiotherapy. Although in its infancy, meta-
bolic proﬁling may in the future be used to monitor response to chemo-
radiotherapy early and hence potentially avoid toxicity effects.ENDOCRINE SURGERY
0196: PARATHYROIDECOMY IN A DISTRICT GENERAL HOSPITAL:
OUTCOMES AND EVOLUTION IN THE ERA OF MINIMALLY INVASIVE
SURGERY
Sharath Paravastu, David Chadwick. Chesterﬁeld Royal Hospital,
Chesterﬁeld, UK
Aim: To determine the outcomes of bilateral neck exploration(BNE)
and uptake as well as outcomes of minimally invasive para-
thyroidectomy(MIP) for primary hyperparathyroidism in a district general
hospital(DGH).
Methods: Review of prospectively maintained database of a single
surgeons' practice for outcomes of BNE and MIP between August 1999 and
December 2010. Patients were considered 'cured' when serum calcium
levels remained normal for more than 6 months after surgery.
Results: 368 patients underwent parathyroidectomy; BNE(n¼314) and
MIP(n¼54). 92 patients underwent preoperative localisation; ultra-
sound(n¼92) and 99TC Sestamibi(MIBI) scan(n¼91). Localisation from
Ultrasound andMIBI was noted in 65%(n¼60) and 71%(n¼65) respectively;
however, concordance between the scans was noted in only 59%(n¼54).
Overall cure rate was 97%. Intention-to-treat analysis, based on preoper-
ative imaging showed cure rates of 96% with BNE and 98% with
MIP(p¼0.53); whereas, based on surgical approach, cure rates were 96.5%
with BNE and 96.3% with MIP(p¼1.0).
Conclusions: Satisfactory cure rates for parathyroidectomy could be ach-
ieved in a DGH. Preoperative localisation studies with ultrasound and MIBI
have a positive concordance rate in only 60% of those considered for MIP,
thereby limiting the use of MIP and reinforcing the role of BNE in this era of
minimally invasive surgery.
0239: IOPANOIC ACID IS SAFE AND EFFECTIVE AS A BRIDGE TO
SURGERY IN THYROTOXICOSIS
Suddendra Doddi, Christopher Buckle, Yazan Masannat, Narayana
Prasad, Abbi Lulsegged, Prakash Sinha. Princess Royal University Hospital,
Bromley, London, UK
Aim: To determine the efﬁcacy and safety of iopanoic acid (IA) in achieving
euthyroidism prior to total thyroidectomy in patients with thyrotoxicosis.
Methods: Between 2007 and 2010, 9 patients with thyrotoxicosis were
treated with IA prior to total thyroidectomy. Data regarding indications for
surgery, dose of IA and ﬁnal outcomes were collected.
Results: The age range of the patients was 22-65 years and mean was 38
years. All were females. The indications for surgery were as follows:
allergic reaction to carbimazole(6 patients), neutropenia (1), propylth-
iouracil induced hepatotoxicity (1) and non-compliance with antithyroid
drugs(1). The mean total dose of IA was 7.7 gm; the range being 4.4 to 10.5
gm. The mean total duration was 4 days. In 8 patients IA was used alone
and in one patient it was used in combination with carbimazole. All ach-
ieved biochemical euthyroidism prior to surgery. Before and after the
